: Define FLT-3 and its shift from a purely leukemic marker to a target in solid tumor immunology.

: Describe how FLT-3 signaling drives hematopoietic cell proliferation and why mutations (like FLT3-ITD) lead to poor prognosis in acute myeloid leukemia (AML).

: Future outlook on bispecific antibodies and combination therapies.

Vitгіria — 3-flt

: Define FLT-3 and its shift from a purely leukemic marker to a target in solid tumor immunology.

: Describe how FLT-3 signaling drives hematopoietic cell proliferation and why mutations (like FLT3-ITD) lead to poor prognosis in acute myeloid leukemia (AML). VitГіria 3-FLT

: Future outlook on bispecific antibodies and combination therapies. : Define FLT-3 and its shift from a